Document is current
Any future updates will be listed below
-
Authors
Alouani, Emily
Rousseau, Benoit
Andre, Thierry https://orcid.org/0000-0002-5103-7095
Marabelle, Aurelien https://orcid.org/0000-0002-5816-3019
- License Information
-
More Information
Article History
First Online: 20 December 2022
Competing interests
: The authors have participated in clinical trials sponsored by Merck Sharp & Dohme, GlaxoSmithKline and Bristol Myers Squibb in the context of patients with MMRd and/or <i>POLE</i>-mutated tumors. Over the past five years, T.A. and A.M. have participated in compensated scientific advisory boards from Merck Sharp & Dohme, GlaxoSmithKline and Bristol Myers Squibb.
